SAN CLEMENTE, CA, Aug. 31, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE ‒ Global WholeHealth Partners Corp. (OTC Pink: GWHP) today announced Goldman Small Cap Research has published an initial analyst report covering GWHP’s outlook.
GWHP is an emerging rapid diagnostic point-of-care (PoC) test kits for hospitals, physicians' offices, and medical clinics in the US and abroad. GWHP was awarded a CE Mark for its high quality, rapid anti-body test for COVID-19 and an EUA filing with the FDA is pending approval. This report carries a price target. To view the new research report, along with disclosures and disclaimers, or to download it in its entirety, please visit https://bit.ly/3lz68yr.
About Goldman Small Cap Research: Founded in 2009 by former Piper Jaffray analyst and mutual fund manager Rob Goldman, Goldman Small Cap Research produces sponsored and non-sponsored small cap and microcap stock research reports, articles, stock market blogs, and popular investment newsletters.
Goldman Small Cap Research is not in any way affiliated with Goldman Sachs & Co.
Goldman Small Cap Research - GWHP
To view an enhanced version of this graphic, please visit:
https://finance.yahoo.com/news/goldman-small-cap-research-issues-120000066.html
This press release contains "forward-looking statements." Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) market acceptance of our existing and new products, (ii) negative clinical trial results or lengthy product delays in key markets, (iii) an inability to secure regulatory approvals for the sale of our products, (iv) intense competition in the medical device industry from much larger, multinational companies, (v) product liability claims, (vi) product malfunctions, (vii) our limited manufacturing capabilities and reliance on subcontractors for assistance, (viii) insufficient or inadequate reimbursement by governmental and other third party payers for our products, (ix) our efforts to successfully obtain and maintain intellectual property protection covering our products, which may not be successful, (x) legislative or regulatory reform of the healthcare system in both the U.S. and foreign jurisdictions, (xi) our reliance on single suppliers for certain product components, (xii) the fact that we will need to raise additional capital to meet our business requirements in the future and that such capital raising may be costly, dilutive or difficult to obtain and (xiii) the fact that we conduct business in multiple foreign jurisdictions, exposing us to foreign currency exchange rate fluctuations, logistical and communications challenges, burdens and costs of compliance with foreign laws and political and economic instability in each jurisdiction. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the Securities and Exchange Commission (SEC), including the Company's Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC's web site at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.
Media Contact:
Name: Charles Strongo
CEO, Global WholeHealth Partners Corp.
Email: investors@gwhpcorp.com
Global WholeHealth Partners Corp. (OTC: GWHP) Signs a Binding MOU With Pan Probe Biotech and AvantGen to Develop the Newest COVID-19 Antigen Test on the Market: 8K Filed on 09/21/2021
Released On: 10/25/2021
Views: 2440
Global WholeHealth Partners Provides Competitive Pricing on Bulk COVID-19 Testing Kits and PPE Supplies
Released On: 10/24/2021
Views: 2421
Global WholeHealth Partners Is The Trusted Provider of Wholesale PPE Supplies and COVID-19 Diagnostic Testing Kits
Released On: 10/22/2021
Views: 2477
Order Medical Grade COVID-19 Diagnostic Testing Kits and PPE Supplies Wholesale Online from Global WholeHealth Partners
Released On: 10/20/2021
Views: 2415
Global WholeHealth Partners Corp (OTC: GWHP) Proudly Announces Its New Manufacturing Facility Which is Able to Triple the Production Volume for the Potential Sales from Walmart, Amazon, eBay and Shopify as Stated in the 8K Filing 08/03/2021
Released On: 10/19/2021
Views: 2429
With COVID-19 Vaccination Rates Increasing Global WholeHealth Partners Continues To Source Premium PPE Supplies and Testing Kits
Released On: 10/18/2021
Views: 2371
Global WholeHealth Partners Sources Superior PPE Supplies and COVID-19 Diagnostic Testing Kits Available for Wholesale Purchase
Released On: 10/16/2021
Views: 2365
Global WholeHealth Partners Corp. (OTC: GWHP), is Approved to Sell Through Walmart, Amazon, eBay and Shopify as Stated in the 8K Filing 08/03/2021; Global's Newly Designed Tests Are Now Ready for the Launch into the Retail Marketplace
Released On: 10/14/2021
Views: 2299
Purchase Superior COVID-19 Diagnostic Testing Kits And Personal Protective Equipment Online from Global WholeHealth Partners
Released On: 10/14/2021
Views: 2946
Global WholeHealth Partners Corp. (OTC: GWHP) Has Been Approved to Sell Its Products Through Walmart and Amazon as Stated in the 8K Filing 08/03/2021; Global's Newly Designed Tests Are Now Ready for the Launch Into the Retail Marketplace
Released On: 10/12/2021
Views: 2306
GWHP Corp Sources Wholesale PPE Supplies and COVID 19 Testing Kits In The Age of Coronavirus and Rising COVID-19 Cases
Released On: 10/10/2021
Views: 2786
Order Bulk PPE Supplies and COVID 19 Diagnostic Testing Kits from Global WholeHealth Partners
Released On: 10/4/2021
Views: 2670
Shop Wholesale PPE Supplies and COVID-19 Tests Available from GWHP Corp Online Today
Released On: 9/30/2021
Views: 2380
Global WholeHealth Partners Corp (OTC: GWHP) Partners With Pan Probe Biotech and AvantGen to Develop the Newest COVID19 Antigen Test on the Market; 8k Filed on 09/21/2021
Released On: 9/29/2021
Views: 2147
GWHP Continues to Source COVID-19 Tests and PPE Supplies As The Delta Variant Continues to Spread
Released On: 9/27/2021
Views: 2632
Partnerships with Key Players Enables GWHP Corp To Source PPE Supplies and COVID-19 Diagnostic Testing Kits
Released On: 9/14/2021
Views: 2670
Global WholeHealth Partners Corp (OTC:GWHP) Now Able to Sell Through Shopify’s Multibillion Dollar Online Platform as Stated in 8k Filing 08/05/21
Released On: 9/14/2021
Views: 2047
Global WholeHealth Partners Provides Wholesale PPE Supplies and COVID-19 Diagnostic Testing Kits
Released On: 9/12/2021
Views: 2689